Last reviewed · How we verify
NCT06255821
The Effect of Time on Generalization of Exposure-based Benefit
NA trial testing Exposure in One Week Follow-up Assessment in 59 participants. Completed in 19 February 2025.
19 February 2025
Quick facts
| Lead sponsor | Ruhr University of Bochum |
|---|---|
| Phase | NA |
| Status | Completed |
| Study type | INTERVENTIONAL |
| Allocation | randomized |
| Design | parallel |
| Masking | none |
| Primary purpose | treatment |
| Enrollment | 59 |
| Start date | 8 July 2024 |
| Primary completion | 19 February 2025 |
| Estimated completion | 19 February 2025 |
| Sites | 1 location across Germany |
Drugs / interventions tested
- Exposure
Conditions studied
- One Week Follow-up Assessment — all drugs for One Week Follow-up Assessment →
- Six Weeks Follow-up Assessment — all drugs for Six Weeks Follow-up Assessment →
- Three Months Follow-up Assessment — all drugs for Three Months Follow-up Assessment →
Sponsor
Ruhr University of Bochum
Who can join
Adults 18 to 40, any sex, with One Week Follow-up Assessment or Six Weeks Follow-up Assessment. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
Participants will receive a pre-assessment and an exposure with a control spider. This control spider will be presented again at post-training assessments. Participants will then be assigned to one of the follow-up assessments: one week, six weeks or three months. The control spider (spider A) and a novel spider (spider B) will be used again at follow-up BATs to test for generalization of exposure effects.
Publications & conference data
No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.
Verify or expand the search:
- PubMed search for NCT06255821
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other trials of Exposure
Trials testing the same drug.
- NCT06564402 — Augmentation of Exposure Using Positive Mental Rehearsal in Individuals With Increased Social Anxiety · NA · recruiting
- NCT06292195 — Effects of Vitamin D on Health Promotion During Pregnancy and Its Impact on Prematurity-Related Outcome · unknown
- NCT05935904 — Progression of Metabolic Syndrome Components During Pregnancy · recruiting
- NCT06132425 — Reward Processes and Rehearsal in Exposure Therapy · NA · completed
- NCT05424250 — Optimizing Exposure Using Occasional Aversive Imagery in Spider Fearful Individuals · NA · completed
Other Ruhr University of Bochum trials
Trials by the same sponsor.
- NCT07432945 — In Vivo Exposure vs. Videochat-Based Vicarious Exposure · NA · recruiting
- NCT05824884 — Self-efficacy Enhancement in a Virtual Reality Training for Fear of Heights · NA · recruiting
- NCT05798078 — The Relationship Between Social Anxiety and Anxious Thinking Styles · NA · completed
- NCT05780203 — CBM in the Context of Exposure for Acrophobia · NA · completed
- NCT05718271 — Effects of Verbal Instructions on Fear Extinction and Extinction Retrieval · NA · completed
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT06255821 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Ruhr University of Bochum
- Last refreshed: 30 January 2026
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT06255821.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing